Marjorie Smith

Title: Marjorie Smith: Innovator in Immunoglobulin Stabilization

Introduction

Marjorie Smith is a notable inventor based in Beckenham, GB. She has made significant contributions to the field of immunology, particularly in the stabilization of immunoglobulin compositions. With a total of 2 patents to her name, her work has had a meaningful impact on the development of therapeutic antibodies.

Latest Patents

One of her latest patents is titled "Method for stabilizing immunoglobulin compositions." This invention relates to a stabilized immunoglobulin composition that includes at least one immunoglobulin along with a stabilizing amount of a chelator of copper ions, such as EDTA or citrate. The preferred immunoglobulin in this composition is an antibody, specifically a recombinant CDR-grafted antibody against the CDw52 antigen, most notably CAMPATH-1H. The patent also describes a process for enhancing the stability of an immunoglobulin by subjecting it to a purification procedure that effectively removes copper ions, ensuring that the immunoglobulin is rendered substantially free from detectable copper ions, as verified by atomic absorption spectroscopy.

Career Highlights

Throughout her career, Marjorie Smith has worked with prominent companies in the pharmaceutical industry, including Glaxo Wellcome Inc. and Burroughs Wellcome Co. Her expertise in immunology and patentable inventions has positioned her as a key figure in her field.

Collaborations

Marjorie has collaborated with various professionals, including her coworker Valentina Riveros-Rojas, who has also contributed to advancements in immunology.

Conclusion

Marjorie Smith's innovative work in stabilizing immunoglobulin compositions showcases her dedication to improving therapeutic solutions in immunology. Her patents reflect her significant contributions to the field and her ongoing influence in the development of effective treatments.